Trials / Recruiting
RecruitingNCT06800612
Evaluating Efficacy and Tolerability of Anticancer Drug Therapies for the Treatment of Gynecologic and Breast Cancers
Observational Study Evaluating the Efficacy and Tolerability of Anticancer Drug Therapies Adopted for the Treatment of Gynecologic and Breast Cancers in Clinical Practice Compared with the Results of Registration Studies
- Status
- Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 100 (estimated)
- Sponsor
- IRCCS Azienda Ospedaliero-Universitaria di Bologna · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
retrospective/prospective observational study. Objective of the study is to evaluate the effect of drugs in terms of objective responses, disease-free survival (DFS), progression-free survival (PFS), overall survival (OS), and side effects compared with registry studies in the medical therapy of breast and gynecologic cancers.
Detailed description
This is a single-center retrospective/prospective observational study. Objective of the study is to evaluate the effect of drugs in terms of objective responses, disease-free survival (DFS), progression-free survival (PFS), overall survival (OS), and side effects compared with registry studies in the medical therapy of breast and gynecologic cancers. Regarding the prospective component of the study, it is clarified that therapy will be warranted by clinical practice regardless of study enrollment. Diagnostic investigations will also be conducted as per normal practice; enrollment in the study does not require additional examinations.
Conditions
- Breast Cancer Early Stage Breast Cancer (Stage 1-3)
- Breast Cancer Metastatic
- Ovarian Cancer
- Cervical Carcinoma
- Endometrial Cancer
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Oncologic drugs administered for treatment of breast cancer | Data on oncologic drugs administered for treatment of breast cancer will be recorded |
| DRUG | Oncologic drug administered for treatment of gynecologic cancer | Data on oncologic drugs administered for treatment of gynecologic cancer will be recorded |
Timeline
- Start date
- 2024-03-22
- Primary completion
- 2030-12-31
- Completion
- 2030-12-31
- First posted
- 2025-01-30
- Last updated
- 2025-01-30
Locations
1 site across 1 country: Italy
Source: ClinicalTrials.gov record NCT06800612. Inclusion in this directory is not an endorsement.